PGNY

Progyny, Inc. [PGNY] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

PGNY Stock Summary

In the News

PGNY Financial details

Company Rating
-
Market Cap
3.3B
Income
62.04M
Revenue
1.09B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
563
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
69.27
Forward P/E
-
PEG
6.93
P/S
3.5
P/B
6.99
P/C
-
P/FCF
18.16
Quick Ratio
3.12
Current Ratio
3.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.66
EPS next Y
-
EPS next Q
-
EPS this Y
96.97%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
36.5%
Revenue Q/Q
-3.9%
EPS Q/Q
-17.65%
-
-
-
-
SMA20
-0.56%
SMA50
-4.59%
SMA100
-2.77%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
12%
ROC
0.1%
Gross Margin
22%
Oper. Margin
5%
Profit Margin
5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
29.44-44.95
52W High
-52.75%
52W Low
-28.31%
RSI
41.74
Rel Volume
1.36
Avg Volume
816.51K
Volume
1.11M
Perf Week
-4.15%
Perf Month
-11.04%
Perf Quarter
41.33%
Perf Half Y
43.48%
-
-
-
-
Beta
1.475
-
-
Volatility
0.31%, 0.47%
Prev Close
-0.91%
Price
20.79
Change
-3.79%

Something similar

Top by Market Cap
CMC.DE
MIX.JO
BRH.DE
TSLA
GOOG
Same Sector
TRVI
BSPK
2395.T
3349.T
COR
Same Price Range
FRCJ.DE
HCA.TO
002317.SZ
1113.HK
GBT.TO
Similar Market Cap
3788.HK
NRP.AS
GYC.DE
SPTJF
AMBBY

Company Profile

Healthcare Medical - Healthcare Information Services
  • Volume Average 816.51K
  • Market Capitalization 3.3B
  • Employee 563
  • CEO Mr. Peter Anevski
  • Headquarters New York,NY,US
  • IPO Date 2019-10-25
  • Website https://www.progyny.com

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.